BELLERI, Mirella
 Distribuzione geografica
Continente #
NA - Nord America 4.792
EU - Europa 2.738
AS - Asia 2.086
SA - Sud America 389
AF - Africa 44
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.057
Nazione #
US - Stati Uniti d'America 4.724
PL - Polonia 1.069
CN - Cina 758
SG - Singapore 644
UA - Ucraina 411
DE - Germania 376
BR - Brasile 324
HK - Hong Kong 249
IT - Italia 206
FI - Finlandia 156
GB - Regno Unito 145
VN - Vietnam 144
RU - Federazione Russa 92
IN - India 75
TR - Turchia 74
IE - Irlanda 70
FR - Francia 54
ES - Italia 51
CA - Canada 37
BD - Bangladesh 30
SE - Svezia 27
ID - Indonesia 26
CZ - Repubblica Ceca 24
ZA - Sudafrica 23
AR - Argentina 18
MX - Messico 17
JP - Giappone 16
EC - Ecuador 13
CL - Cile 12
AT - Austria 11
NL - Olanda 10
BE - Belgio 8
PH - Filippine 8
PK - Pakistan 8
VE - Venezuela 8
IQ - Iraq 7
IR - Iran 7
MA - Marocco 7
CO - Colombia 6
JM - Giamaica 6
LT - Lituania 6
IL - Israele 5
KE - Kenya 5
PT - Portogallo 5
SA - Arabia Saudita 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
PE - Perù 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
PA - Panama 3
AZ - Azerbaigian 2
CH - Svizzera 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
NO - Norvegia 2
RO - Romania 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.057
Città #
Warsaw 1.068
Fairfield 580
Ashburn 464
Woodbridge 383
Singapore 307
Jacksonville 302
Houston 295
Ann Arbor 251
Hong Kong 247
Cambridge 234
Chandler 220
Seattle 205
Beijing 188
Wilmington 184
Dallas 146
Princeton 127
Nanjing 105
Los Angeles 104
New York 93
Brescia 90
Helsinki 81
Dublin 70
Dearborn 64
Istanbul 63
Dong Ket 60
Munich 59
San Francisco 42
Madrid 38
The Dalles 38
Des Moines 34
São Paulo 34
Nanchang 32
Buffalo 30
Shanghai 30
Chicago 27
Ho Chi Minh City 27
Jinan 27
Lancaster 27
Hebei 26
San Diego 26
Moscow 25
Changsha 23
Milan 23
Redondo Beach 23
Santa Clara 23
Shenyang 23
Hanoi 20
London 20
Boardman 19
Jakarta 19
Turku 19
Tianjin 18
Rio de Janeiro 17
Brno 16
Brooklyn 16
Johannesburg 15
Orem 15
Phoenix 15
Tokyo 15
Washington 15
Boston 14
Jiaxing 14
Guangzhou 13
San Mateo 13
Stockholm 13
Toronto 13
Lanzhou 11
Ningbo 11
Nuremberg 10
Atlanta 9
Charlotte 9
Chennai 9
Kunming 9
Montreal 9
Zhengzhou 9
Brussels 8
Denver 8
Haikou 8
Hangzhou 8
Paris 8
Dhaka 7
Quito 7
Redwood City 7
Ardabil 6
Kingston 6
Modena 6
Olomouc 6
Poplar 6
Porto Alegre 6
Querétaro 6
Verona 6
Vienna 6
Belo Horizonte 5
Bergamo 5
Changchun 5
Falkenstein 5
Frankfurt am Main 5
Fuzhou 5
Gunzenhausen 5
Haiphong 5
Totale 7.128
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 316
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 299
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 283
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 281
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 263
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 263
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 258
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 251
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 245
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 203
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 202
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 195
Anti-angiogenic activity of the purine analog 6-thioguanine. 194
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 191
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 188
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 187
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 185
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 183
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 169
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 165
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 162
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 161
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 157
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 156
Beta-Galactosylceramidase deficiency: neurovascular implications 154
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 148
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 145
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 144
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 138
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 138
Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. 130
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 128
Non competitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation 126
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist 122
In vitro and ex vivo retina angiogenesis assays 122
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. 120
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 120
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 120
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 120
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 118
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT 118
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 118
A novel ex vivo murine retina angiogenesis (EMRA) assay 117
Undersulfated and glycol-split heparins endowed with antiangiogenic activity 116
Endothelial cell dysfunction in globoid cell leukodystrophy 116
Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells: an in vitro autocrine model of angiogenesis in brain tumors 115
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 113
Role of inflammation in FGF2-driven angiogenesis 112
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 112
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice. 108
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 108
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 108
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 106
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 106
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 102
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 102
Inhibition of angiogenesis in Krabbe's disease: endothelial cytoskeleton disassembly by the glycosphingolipid psychosine 98
Globoid cell leukodystrophy: inhibition of angiogenesis by beta-galactosylceramidase deficiency 92
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 91
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 88
The Urokinase Receptor-Derived Peptide UPARANT Inhibits Pathological Retinal Angiogenesis 84
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 83
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process 79
In Vitro and In Vivo Efficacy on Retinal Neo-Vascularization of an Innovative Broad-Range Anti-Angiogenic Synthetic Peptide (Uparant) 76
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos 75
Integrin -dependent antiangiogenic activity of resveratrol stereoisomers 68
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 64
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice 64
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 63
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 60
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist 52
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease 50
β-Galactosylceramidase in cancer: more than a psychosine scavenger 35
Totale 10.249
Categoria #
all - tutte 43.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021808 0 0 0 0 0 124 39 148 146 113 123 115
2021/2022621 26 134 15 15 12 25 36 30 26 105 53 144
2022/2023554 88 31 26 44 50 135 6 49 70 4 24 27
2023/2024719 47 41 106 26 42 107 33 21 136 34 19 107
2024/20251.358 18 11 5 193 130 142 117 65 153 82 264 178
2025/20261.788 311 366 291 443 347 30 0 0 0 0 0 0
Totale 10.249